Download App

Log in to access Online Inquiry
Company Overview More
Jiakos Pharmaceutical Group Co., Ltd. is a Chinese investment holding company mainly engaged in clinical drug research and development. The company is mainly responsible for the independent discovery and development of innovative tumor therapy. The company's main drug development projects include JAB-3068 and allosteric SHP2 inhibitors in the clinical phase of JAB-3312. The company mainly does business in the domestic market.
CEO: Yinxiang Wang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 01167 JACOBIO-B > Detailed Quotes

01167 JACOBIO-B

7.550+0.150+2.03%
Trading Session 05/24 13:46 CCT
High
7.620
Open
7.440
Turnover
6.48M
Low
7.310
Pre Close
7.400
Volume
868.80K
Market Cap
5.82B
P/E(TTM)
Loss
52wk High
23.700
Shares
771.46M
P/E(Static)
Loss
52wk Low
6.380
Float Cap
5.82B
Bid/Ask %
-8.06%
Historical High
25.350
Shs Float
771.46M
Volume Ratio
0.91
Historical Low
6.380
Dividend TTM
--
Div Yield TTM
--
P/B
2.91
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.11%
Amplitude
4.19%
Avg Price
7.458
Lot Size
300
Float Cap
5.82B
Bid/Ask %
-8.06%
Historical High
25.350
Shs Float
771.46M
Volume Ratio
0.91
Historical Low
6.380
Dividend TTM
--
P/B
2.91
Dividend LFY
--
Turnover Ratio
0.11%
Amplitude
4.19%
Avg Price
7.458
Lot Size
300
Price Forecast

No Data

News

Comment